Interaction Study SLV337/Simvastatin

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: Male

Summary

To investigate the effect of multiple doses of SLV337 on the pharmacokinetics of simvastatin and simvastatin acid when co-administered in healthy male subjects

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Solvay Pharmaceuticals
• Treatments: Simvastatin

Criteria

Inclusion Criteria:

• Volunteers with Body Mass Index 18.0-28.0 kg/m2

Exclusion Criteria:

• Clinically relevant medical history